Official neurology podcast of the European Academy of Neurology (EAN). Expert talks on general neurology, stroke, dementia, epilepsy & many more. New episodes every Monday. For neurology residents, clinicians & researchers. A resource for continuing medical education and lifelong learning.
All content for eanCast: Weekly Neurology is the property of ean.org and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Official neurology podcast of the European Academy of Neurology (EAN). Expert talks on general neurology, stroke, dementia, epilepsy & many more. New episodes every Monday. For neurology residents, clinicians & researchers. A resource for continuing medical education and lifelong learning.
Moderator: Rob Hadden (London, United Kingdom)
Guest: Claudia Sommer (Würzburg, Germany)
In this episode, Rob Hadden and Claudia Sommer discuss ongoing challenges in treating CIDP. While most patients benefit from current therapies, some remain treatment-refractory, driving the need for innovation. They highlight emerging response definitions, promising FcRn and complement inhibitors, and the importance of individualized care and serum biomarkers for improving patient outcomes.
This episode has been supported by an educational grant from Argenx. The programme has not been influenced in any way by its supporter.
eanCast: Weekly Neurology
Official neurology podcast of the European Academy of Neurology (EAN). Expert talks on general neurology, stroke, dementia, epilepsy & many more. New episodes every Monday. For neurology residents, clinicians & researchers. A resource for continuing medical education and lifelong learning.
